Market News & Trends
NantWorks to Invest $85.5 Million, Creating New Jobs & Drugs
California-based NantWorks, LLC, recently announced plans to locate a new pharmaceutical manufacturing plant in Terre Haute, Indiana, creating up to 234 new jobs by 2016.…
Sigma-Aldrich to Acquire BioReliance Corporation for $350 Million
BioReliance, a leading provider of global biopharmaceutical testing services, recently announced it has agreed to be acquired by Sigma-Aldrich Corporation. Avista Capital Partners, the majority…
Ventana Medical Systems & Cell Signaling Technology to Collaborate With Pfizer on Companion Diagnostic
Ventana Medical Systems, Inc., a member of the Roche Group, recently announced it has entered into a collaboration agreement with Pfizer Inc. and license agreement…
Xenon Pharmaceuticals Signs $646 Million Pain Pact With Roche
Xenon Pharmaceuticals, Inc. recently announced a strategic alliance with Genentech, a member of the Roche Group, to discover and develop compounds and companion diagnostics for…
Thermo Fisher Scientific Uses New Method to Determine Sialic Acids in Glycoproteins
Thermo Fisher Scientific recently announced a new method that uses high-performance anion-exchange chromatography with pulsed amperometric detection (HPAE-PAD) to determine sialic acids in glycoproteins. Application…
Veloxis Pharmaceuticals & Athena Drug Delivery Solutions Announce Partnership
Veloxis Pharmaceuticals and Athena Drug Delivery Solutions recently announced an alliance in which Athena will obtain exclusive rights in certain emerging market territories to manufacture…
1/10/2012
Particle Sciences Expands Program With Additional Proprietary Modeling Capabilities Particle Sciences recently announced it has added a third computational module to its DOSE program. The…
Isotechnika & Vifor Pharma Enter Development & Commercialization Agreement
Isotechnika Pharma Inc. recently announced it has signed a global development and commercialization license agreement with Vifor Pharma Ltd., the specialty pharma company of Switzerland-based…
Novavax Reports Significant Vaccine Development Progress
Novavax, Inc. recently announced that CPL Biologics (CPLB), its joint venture in India with Cadila Pharmaceuticals Ltd., has made significant progress with its vaccine development…
Particle Sciences Expands Program With Additional Proprietary Modeling Capabilities
Particle Sciences recently announced it has added a third computational module to its DOSE program. The DOSE program uses a combination of empirical data and…
12/20/2011
Enlight Biosciences Forms Lucrative New Partnerships Enlight Biosciences LLC recently announced today it has formed new partnerships with AstraZeneca and Novo Nordisk. As partners in…
Covidien Plans Spin-off of Pharmaceuticals Business
Covidien plc, a leading global provider of healthcare products, recently announced it plans to spin off its pharmaceuticals business into a stand-alone public company. Covidien's…
DSM Signs Capsules Contract With QRxPharma
DSM Pharmaceutical Products, the custom manufacturing business of Royal DSM N.V., recently announced the signing of a manufacturing and supply agreement with QRxPharma, Inc., based…
Enlight Biosciences Forms Lucrative New Partnerships
Enlight Biosciences LLC recently announced today it has formed new partnerships with AstraZeneca and Novo Nordisk. As partners in Enlight, AstraZeneca and Novo Nordisk will…
Ezose Sciences Forms New Biomarker Agreement With Merck
Ezose Sciences Inc. recently announced it has entered an agreement with Merck, through a subsidiary, to collaborate on biomarker discovery research in the field of…
ProJect Pharmaceutics Introduces Predictive Formulation Analytics for Optimized Biopharmaceutical Formulations
Protein drug formulation is particularly challenging due to structural complexity and instability. The biological activity of most recombinant proteins emanates specifically from their three-dimensional structure,…
Pulmatrix Presents iSPERSE Data for Inhaled Combination Therapies
Pulmatrix recently announced that its iSPERSE inhaled drug platform demonstrated multi-drug delivery capability and superiority over conventional lactose blending for an effective therapeutic dose of…
12/13/2011
Abbott Laboratories Spends $400 Million on Development Deal Abbott Laboratories and Reata Pharmaceuticals recently announced they have entered into a worldwide collaboration to jointly develop and…
Abbott Laboratories Spends $400 Million on Development Deal
Abbott Laboratories and Reata Pharmaceuticals recently announced they have entered into a worldwide collaboration to jointly develop and commercialize Reata's portfolio of second-generation oral antioxidant…
Aptar Pharma's Ophthalmic Dispenser Chosen for Eyecare Product
Aptar Pharma recently announced its innovative and patented preservative-free multidose Ophthalmic Squeeze Dispenser (OSD) has found its first application for the treatment of dry eye…
